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Abstract
To compare gastrointestinal (GI) problems among children with: (1) autism 
spectrum disorder (ASD), (2) developmental delay (DD) and (3) typical devel-
opment (TD), GI symptom frequencies were obtained for 960 children from 
the CHildhood Autism Risks from Genetics and Environment (CHARGE) study. 
We also examined scores on five Aberrant Behavior Checklist (ABC) subscales 
comparing ASD children with high versus low frequency GI symptoms. Com-
pared to TD children, those with ASD [aOR 7.92 (4.89–12.85)] and DD [aOR 
4.55 (2.51–8.24)] were more likely to have at least one frequent GI symptom. 
Restricting to ASD children, those with frequent abdominal pain, gaseousness, 
diarrhea, constipation or pain on stooling scored worse on irritability, social 
withdrawal, stereotypy, and hyperactivity compared with children having no 
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frequent GI symptoms. Frequent GI problems affect young children with ASD 
and DD more commonly than those with TD. Maladaptive behaviors correlate 
with GI problems, suggesting these comorbidities require attention. 
Keywords: Gastrointestinal problems, Autism, Developmental delays, Mal-
adaptive behaviors 
Introduction 
Frequent anecdotal reports of gastrointestinal (GI) problems in chil-
dren with autism spectrum disorder (ASD) are beginning to be clari-
fied by research efforts examining the issue. The connection between 
GI problems and autism is not yet resolved, however, and a handful 
of recent reports provide conflicting findings, where prevalence of GI 
symptoms ranges from 23 to 70 % (Molloy and Manning- Courtney 
2003; Valicenti-McDermott et al. 2006; Ibrahim et al. 2009; Nikolov et 
al. 2009; Wang et al. 2011; Gorrindo et al. 2012). Variations in preva-
lence of GI problems in large part may be due to differences across 
studies including, but not limited to: variations in the criteria used to 
define a GI problem, the number of different GI symptoms consid-
ered, the definition of any particular GI symptom or lack thereof, vari-
ations in methodology such as data source (medical chart versus self-
report) or time period for reporting (last few months, lifetime, etc.), 
and study population characteristics such as age and other criteria 
for participation. 
Research using large samples has begun to provide a better un-
derstanding of the heterogeneity of GI concerns in children with ASD 
(Molloy and Manning-Courtney 2003; Valicenti-McDermott et al. 2006; 
Ibrahim et al. 2009; Nikolov et al. 2009; Wang et al. 2011). However, for 
comparative purposes, few estimates of GI symptom prevalence are 
available for children with typical development (TD). Instead, research 
has focused on GI issues for groups that seem disproportionately af-
fected, namely children with ASD, and more recently, children with de-
velopmental disabilities (Schieve et al. 2012). Among the first of these 
was a study (n = 137) using medical records from a clinic specializing 
in ASD in a large pediatric medical center serving a 10 county catch-
ment area in the Midwest (Molloy and Manning-Courtney 2003). The 
study considered solely four GI symptoms and the definitions were 
relatively restrictive, which may partially explain prevalence of 24 % in 
this study population. Nikolov and colleagues evaluated GI problems 
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in a sample (n = 172) of children with pervasive developmental dis-
orders (PDDs) enrolled for one of two randomized clinical trials. They 
defined a GI problem as one that caused impairment in function, had 
been brought to the attention of a medical professional and had been 
or was currently under treatment. They reported 22 % of their sample 
was positive for GI problems, which were primarily constipation and 
diarrhea (Nikolov et al. 2009). 
A few other studies attempted to not only characterize GI disorders 
in children with ASD but also make comparisons to other groups of chil-
dren. Valicenti-McDermott et al. carried out a cross-sectional case–con-
trol study (n = 50 in each group) in English and Spanish-speaking fam-
ilies with ASD, TD and DD (Valicenti-McDermott et al. 2006). Children 
between 1 and 18 years of age were matched for age, gender and eth-
nicity, and findings indicated a lifetime reported history of 1 or more GI 
symptoms was higher in cases (ASD 70 %) than both controls (TDs 28 
%, DDs 42 %). Another recent case–control population based study (n = 
121 cases, n = 242 controls) in Olmstead County, Minnesota, where >95 
% of medical care is provided by Olmstead Medical Center/Mayo Clinic, 
medical charts provided data for GI symptoms from birth to 21 years of 
age (Ibrahim et al. 2009). Out of the five GI categories compared, only 
constipation and food selectivity were higher in ASD cases as compared 
with controls, but potential inclusion of illness episodes in a 21 year pe-
riod could have skewed results, and 98 % of racial/ethnic makeup was 
white, raising the issue of generalizability of findings. Finally, in a study 
using data from the Autism Genetic Resource Exchange (AGRE) where 
only families with multiple affected members are included, parents re-
ported significantly more GI problems in children with ASD than in their 
unaffected siblings (42 vs. 12 %; Wang et al. 2011). Furthermore, this 
was the first study to report that having increased autism severity was 
associated with higher odds of GI problems. 
In light of the existing literature of variable methodologies and 
findings, our study provides the largest ethnically diverse population-
based case–control study to date that compares GI problems for chil-
dren with clinically confirmed: (1) ASD, (2) DD and (3) TD. It also is the 
first large population-based sample that examines the relationship of 
GI symptoms and maladaptive behaviors. Understanding the magni-
tude of GI problems and their effects on behavior can provide new 
insight for more effective and appropriate treatment of children who 
suffer from these problems. 
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Methods 
Study Design and Sample 
The CHildhood Autism Risks from Genetics and the Environment 
(CHARGE) study is an ongoing population based case–control study 
with participants sampled from three strata: children with (ASD), chil-
dren with DD but not ASD, and children selected from the general 
population (Hertz-Picciotto et al. 2006). Recruitment began in April 
2003, and a total of 1,513 participants were enrolled in this CHARGE 
study sample from April 2003 through May 2011. All participating 
children meet the following criteria: (a) are between the ages of 24 
and 60 months, (b) live with at least one biologic parent, (c) have a 
parent who speaks English or Spanish, (d) were born in California, 
and (e) reside in one of the catchment areas of a specified list of Re-
gional Centers in California. All subjects were assessed to confirm di-
agnostic group and parents completed standardized interviews and 
questionnaires about their children’s past history and present behav-
ior and functioning. Diagnosis of ASD was confirmed in all subjects 
by the Autism Diagnostic Interview-Revised (ADI-R) (Le Couteur et 
al. 1993) and the Autism Diagnostic Observation Schedules (ADOS) 
(Lord et al. 2003). Details have been described previously (Hertz-Pic-
ciotto et al. 2006) in which children that met full criteria for autism on 
both the ADI-R and ADOS were classified as autism (AU), and chil-
dren that came within two points of meeting criteria for autism on 
the communications or social domains of the ADI-R and met crite-
ria on ADOS were classified as ASD. Since there was little difference 
in GI symptoms between the AU and ASD groups, we have combined 
them, hereafter designated as ASD for comparisons among children 
with an ASD, DD and TD. All children were assessed with the Mullen 
Scales of Early Learning (Mullen 1995) and the Vineland Adaptive Be-
havior Scales (VABS) (Sparrow 1984). Children recruited into the DD or 
TD group were also screened with the social communication question-
naire (SCQ); children with scores at or above 15 points were referred 
for assessment of ASD using the ADOS and ADI-R.). We defined DD 
based on composite scores for Mullen Scales of Early Learning (MSEL) 
and VABS. A child was classified as DD if he/she did not meet crite-
ria for ASD, scored<70 on either MSEL or VABS and scored <77 on 
the other assessment. Children were classified as TD if their MSEL and 
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VABS scores were both>70 and they scored<15 on the SCQ. For pur-
poses of this analysis, we excluded participants missing the Gastroin-
testinal History (GIH) questionnaire (n = 313), siblings of target chil-
dren (n = 26), participants with an incomplete or pending diagnosis 
(n = 187), those with evidence of developmental delay on only one 
of two instruments (n = 24) and those missing data on child’s race (n 
= 3). The final study population therefore consisted of 960 children. 
The study was approved by institutional review boards for the 
State of California and the University of California, Davis and Los 
Angeles. Informed consent is obtained for all participants prior to 
data collection. 
Measures and Procedures 
Prior to clinic visits, participants are mailed several self adminis-
tered questionnaires including the CHARGE GIH and the Aberrant 
Behavior Checklist (ABC). Maladaptive behavior was measured using 
five subscales of the ABC: irritability (15 items), lethargy/social with-
drawal (16 items), stereotypy (7 items), hyperactivity (16 items) and 
inappropriate speech (4 items; Aman and Singh 1994). ABC subscales 
scores ranged based on the number of items scored using a 4 point 
Likert scale (0 = Not at all a problem; 1 = Problem slight in degree; 2 
= Problem moderately serious; 3 = Problem severe in degree). The GIH 
includes 10 Likert scale items (0 = never; 1 = rarely; 2 = sometimes; 
3 = frequently; 4 = always) for each current gastrointestinal symp-
tom (abdominal pain, gaseousness/ bloating, diarrhea, constipation, 
pain on stooling, vomiting, sensitivity to foods, difficulty swallowing, 
blood in stool and blood in vomit). ‘‘Current’’ was defined as the past 
3 months. Additionally, the GIH includes four (yes/ no) questions ask-
ing about the presence of food allergies, diet restrictions, food dis-
likes and whether any GI diagnosis has ever been given. Finally, there 
are open-ended questions asking parents to list: food allergies; rea-
sons for diet/food restrictions; and what GI condition was diagnosed. 
Other data collected as part of the CHARGE Study protocol include 
demographics and medications used in the last month. A pediatri-
cian reviewed our list of medications and declared a vast majority of 
them were known to have some GI side effects, including medica-
tions for cold symptoms, allergies, pain relief, and antibiotics. We did 
not control for medications known to be used in the treatment of GI 
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symptoms such as anti-diarrheal medications or those used to treat 
constipation or gastroesophageal reflux disorder (GERD). 
Statistical Procedures 
Demographic characteristics were examined across groups for ASD, 
DD and TD using likelihood ratio Chi square tests for categorical vari-
ables. We dichotomized the Likert scale items on the GIH into symp-
toms that occur with ‘high’ (items ranked either frequently or always) 
versus ‘low’ frequency (items ranked never, rarely or sometimes). We 
tested for differences in reported frequency of GI symptoms and food 
allergies, diet restrictions, strong food dislikes, and GI diagnoses us-
ing the likelihood ratio Chi square statistic. Odds ratios adjusted for 
child age, child gender and maternal education, along with 95 % con-
fidence intervals (CI), were calculated for a report of high frequency 
for at least one GI symptom, and then separately for each individual 
GI symptom, comparing ASD and DD case groups with TD as the ref-
erence. To also control for the possible confounding effect of medica-
tions known to have GI side effects, an additional set of analyses was 
conducted on a smaller sample size (n = 622, due to missing medi-
cation data). Within the ASD and DD groups, we used Wilcoxon rank 
sum test or t-tests to examine differences in scores on the five sub-
scales of the ABC, comparing children with high versus low frequency 
of GI symptoms. 
Responses provided by parents for open-ended GI questions were 
categorized and tallied by the first author (i.e., reported food allergies, 
reasons for diet restrictions, and reported GI diagnoses) and catego-
ries were reviewed by remaining authors, one of whom is a clinician. 
All statistical analyses were carried out using SAS version 9.2 (SAS In-
stitute Inc., Cary, NC, USA). 
Results 
Study Population Characteristics 
Mothers of children with developmental delay tended to have less 
formal education than mothers of children with TD or ASD. Roughly 
half of the study population was white, while approximately one-third 
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was of Hispanic origin. Reported medication use was higher in chil-
dren with DD compared to children with TD or ASD (Table 1). 
Table 1 Characteristics and medication use for cases autism spectrum disorder (ASD), develop-
mental delay (DD) and controls typical development (TD). CHARGE study 2003–2011 
 ASD  Controls TD  DD  p valuea 
 n = 499  n = 324  n = 137 
Maternal age     0.29 
   Mother’s age ≥35 at delivery  27.1 %  22.2 %  25.6 % 
Maternal education          <0.0001 
   Less than high school  3.8 %  5.3 %  15.3 % 
   High school diploma/GED  9.8 %  11.1 %  13.9 % 
   Some college/2 year degree  41.7 %  32.4 %  40.2 % 
   Bachelor degree  28.5 %  34.6 %  25.6 % 
   Graduate or professional degree  16.2 %  16.7 %  5.1 % 
Race/ethnicity (child)          0.02 
   White  50.5 %  52.5 %  41.6 % 
   Hispanic  32.1 %  29.0 %  39.4 % 
   Black  2.4 %  1.9 %  5.1 % 
   Asian  5.6 %  2.5 % 1 .5 % 
   Pacific Islander  0.0 %  0.3 %  0.0 % 
   Multi-racial  9.4 %  13.9 %  12.4 % 
Male gender 85.8 %  83.0 %  63.5 %  <0.0001a 
Child age in yearsb           0.004 
   2 year olds (24–35 months)  22.4 %  30.6 %  14.6 % 
   3 year olds (36–47 months)  36.1 %  36.4 %  38.0 % 
   4 year olds (48–59 months)  39.1 %  31.2 %  46.0 % 
   5 year olds (60 months ?)  2.4 %  1.9 %  1.5 % 
Regression status (cases only)  44.9 %  na  na 
MSELc 
   Mean ± SD  61.5 ± 17.8  106 ±17. 4 53.6 ± 7.1 
   Range  49–136  70–149  49–76 
VABSd 
   Mean ± SD  64.5 ± 12.6  104.5 ± 15  58.9 ± 8.8 
   Range  40–150  70–145  33–76 
Medication use  n = 465  n = 315  n = 131 
   Ever used any 
      conventional treatments?  23.2 %  10.5 %  39.7 %  <0.0001 
      psychiatric treatments?  1.5 %  0.0 %  3.8 %  0.002 
      anticonvulsants or benzodiazepines?  3.7 %  0.0 %  13.7 %  <0.0001 
      CAM treatment?  26.7 %  3.5 %  19.9 %  <0.0001 
p values calculated for comparisons across groups using Chi-square test or Fisher’s exact test 
a The TD group was frequency matched to the projected gender distribution of the autism cases, 
while the DD group was not matched at all 
b Reflects age at assessment which occurs within a few months after recruitment. All children 
were recruited between 24 and 60 months of age 
c Mullen Scales of Early Learning 
d Vineland Adaptive Behavior Scales 
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Comparisons of GI Symptom Reports Across Diagnostic Groups 
of ASD, DD and TD 
Parent report of at least one frequent GI symptom was significantly 
higher for children with ASD and children with DD, compared to chil-
dren with TD. Comparison of parent reports suggests that children 
with either ASD or DD are far more likely to have frequent constipa-
tion, diarrhea and difficulty swallowing than children with TD (Table 2). 
Group differences in GI symptoms for children with ASD held up after 
adjusting for child age, child gender, and maternal education (Table 3). 
Children with ASD were at least three times more likely to experience 
frequent GI symptoms than children with TD: abdominal pain, pain 
on stooling, constipation, gaseousness/bloating, diarrhea, sensitivity 
to foods, as well as vomiting and difficulty swallowing, which were 
very rare in TD controls. Similarly, reported food allergies, food re-
strictions, and food dislikes were highest in children with ASD (Table 
Table 2 Comparison of ‘Current’ GI symptoms (in the past 3 months) for cases (ASD) and controls (TD 
and DD). CHARGE study 2003–2011 
 ASD  TD  DD  p valuea  AU  ASD  p valueb 
 n=499  n=324  n=137   n=339  n=160  
 (%) (%)  (%)   (%)  (%)  
GI symptomsb 
Abdominal pain  5.1  1.6  3.9  0.03  5.9  3.5  0.27 
Gaseousness/bloating sensation  11.0  2.0  2.3  <0.0001  11.7  9.6  0.51 
Diarrhea  13.0  1.6  6.1  <0.0001  16.1  6.4  0.002 
Constipation  15.5  3.5  15.8  <0.0001  16.8  12.5  0.22 
Pain on stooling  6.2  1.6  5.5  0.004  7.4  3.4  0.08 
Vomiting  2.9  0.3  6.2  0.0006  2.7  3.2  0.76 
Sensitivity to foods  31.0  4.5  11.1  <0.0001  32.1  28.9  0.49 
Difficulty swallowing 4.2  0.3  4.6  0.0005  4.0  4.6  0.77 
Blood in stools  0.4  0.3  0.8  0.62  0.6  0.0  1 
Blood in vomit  0.2  0.0  0.0  1  0.0  0.6  0.32 
Presence of related issuesc 
Food allergies Y/N  23.0  11.1  13.5  <0.0001  19.7  20.3  0.88 
Food restrictions Y/N  37.4  10.4  21.6  <0.0001  40.2  31.4  0.06 
Food dislikes Y/N  63.5  34.0  34.6  <0.0001  63.8  62.9  0.89 
GI diagnosis Y/N  7.5  1.9  22.9  <0.0001  7.8  6.9  0.7 
Those reporting symptoms occur ‘frequently’ or ‘always’ on Likert scale 
a p values calculated for comparisons across groups using Chi-square test or Fisher’s exact test 
b Number of missing data for entire sample for the first ten GI question varies from 29 to 77 
c Number of missing data for entire sample for the last four questions varies from 19 to 38 (except 
‘food dislikes’ missing = 332) 
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2). However, parent report of a GI diagnosis was highest in children 
with DD compared to children with ASD and TD. Moreover, children 
with DD were at least three times more likely than children with TD 
to experience frequent sensitivity to foods, pain on stooling, diarrhea, 
constipation, as well as difficulty swallowing and vomiting. 
Analyses using those with parent-report medication data confirm 
that after adjusting for medications with potential GI side effects, most 
findings were essentially unchanged: children with ASD are approxi-
mately six to eight times more likely to report frequent gaseousness/
bloating, constipation, diarrhea and sensitivity to foods regardless of 
which variables were controlled (Table 3). Similarly, parents of children 
with DD were five-fold more likely to report constipation, as well as 
significantly more likely to report difficulty swallowing and vomiting 
compared to parents of TD children after adjusting for medications 
Table 3 Odds ratio of ‘Current’ GI symptoms (in the past 3 months) for ASD with typical development (TD) as 
reference group. CHARGE study 2003–2011 
GI symptoms  Unadjusted  95 % CI  Adjusted  95 % CI  Adjusted  95 % CI  
 odds ratio   odds ratioa   odds ratiob
ASD versus TD 
Full study populationc (n = 960) 
Abdominal pain   3.28 (1.23–8.72)  3.26 (1.21–8.78)  na  na 
Gaseousness/bloating   6.15 (2.60–14.54) 6.43  (2.71–15.29)  na  na 
Diarrhea  9.08 (3.61–22.84) 9.43 (3.73–23.83) na  na 
Constipation   5.02  (2.62–9.62) 5.41 (2.81–10.41)  na na 
Pain on stooling  4.03  (1.54–10.52)  4.20  (1.60–11.03) na  na 
Vomiting  9.08 (1.19–69.38)e 9.83  (1.28–75.40)e  na na 
Sensitivity to foods  9.51 (5.37–16.83) 9.67  (5.44–17.18) na  na 
Difficulty swallowing 13.29  (1.77–99.53)e 12.57  (1.67–94.71) na  na 
Subset with medication datad (n = 622) 
Abdominal pain   3.14  (1.11–8.87) 3.01 (1.05–8.64)  2.85  (0.99–8.24) 
Gaseousness/bloating   6.13 (2.31–16.25) 6.14 (2.29–16.49)  5.93  (2.20–15.98) 
Diarrhea   6.35 (2.16–18.65)  6.09  (2.06–18.03)  6.19  (2.09–18.33) 
Constipation  5.76  (2.63–12.62)  6.07 (2.74–13.43)  6.06  (2.74–13.42) 
Pain on stooling   2.8 (0.98–7.97) 2.91  (1.01–8.41)  2.84 (0.98–8.21) 
Vomiting  7.21  (0.88–59)e  7.72  (0.93–64.16)e  8.04  (0.97–67)e 
Sensitivity to foods  8.61  (4.62–16.07)  8.6  (4.58–16.14) 8.57 (4.56–16.09) 
Difficulty swallowing   7.23 (0.88–59.20)e  6.56  (0.79–54.3)e  6.89 (0.83–57.5)e 
Those reporting symptoms occur ‘frequently’ or ‘always’ on Likert scale 
a Adjusted for child’s age, gender, maternal education 
b Adjusted for child’s age, child’s gender, maternal education, and medication 
c TD group n = 324, ASD group n = 499, DD group n = 137 
d TD group n = 257, ASD group n = 254, DD group n = 111 
e Wide confidence interval (CI) is a result of only one control having this symptom 
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(Table 4). The exclusion of those without medication data appears to 
have resulted in a somewhat lower prevalence of reported diarrhea. 
We did not find any meaningful differences between ASD children 
with DD (n = 114), ASD without DD (n = 377) and DD without ASD 
(our DD group), beyond what the previous analyses have already de-
scribed. Specifically, GI symptoms did not significantly differ compar-
ing ASD with DD versus ASD without DD, with the exception of vom-
iting. Vomiting is a relatively infrequent GI symptom reported, and 
ASD without DD had higher occurrence than ASD with DD (p = 0.02; 
Table 1S). 
Table 4 Odds ratio of ‘Current’ GI symptoms (in the past 3 months) for DD with TD as reference group. CHARGE study 
2003–2011 
GI symptoms  Unadjusted  95 % CI  Adjusted  95 % CI  Adjusted  95 % CI  
 odds ratio  odds ratioa  odds ratiob
DD versus TD 
Full study populationc (n = 960) 
Abdominal pain 2.48  (0.71–8.73) 2.09 (0.56–7.73) na  na 
Gaseousness/bloating 1.19  (0.29–4.86)  1.39  (0.33–5.76)  na na 
Diarrhea 3.97 (1.27–12.36) 4.71  (1.48–15.01) na  na 
Constipation  5.15 (2.41–11.02)  4.77 (2.17–10.46)  na  na 
Pain on stooling 3.58  (1.12–11.50)  3.70  (1.11–12.31)  na na 
Vomiting 20.2  (2.5–163.19)e  24.00  (2.88–200.24)e na  na 
Sensitivity to foods 2.64  (1.22–5.72) 3.14 (1.43–6.92)  na  na 
Difficulty swallowing  14.85 (1.77–124.65)e  10.42 (1.20–90.27)e  na  na 
Subset with medication datad (n = 622) 
Abdominal pain  1.46  (0.34–6.24) 1.33  (0.30–6.01) 1.19  (0.23–5.45) 
Gaseousness/bloating 0.95 (0.18–4.99) 1.08  (0.20–5.85)  0.93  (0.17–5.10) 
Diarrhea 2.41  (0.59–9.80)  2.38 (0.56–10.05) 2.51 (0.59–10.64) 
Constipation 5.28 (2.18–12.75)  4.92 (1.97–12.32) 4.91 (1.96–12.31) 
Pain on stooling  2.53 (0.72–8.94)  3.06 (0.83–11.33) 2.9  (0.78–10.83) 
Vomiting 15  (1.78–126.21)e  17.83 (2.01–158.34)e  20.86  (2.3–189.5)e 
Sensitivity to foods 1.75 (0.73–4.24)  2.03  (0.82–5.04)  2.01 (0.81–5) 
Difficulty swallowing  12.32  (1.42–106.69)e  9.36  (1.02–85.77)e  12.32 (1.31–115.83)e 
Those reporting symptoms occur ‘frequently’ or ‘always’ on Likert scale 
a Adjusted for child’s age, gender, maternal education 
b Adjusted for child’s age, child’s gender, maternal education, and medication 
c TD group n = 324, ASD group n = 499, DD group n = 137 
d TD group n = 257, ASD group n = 254, DD group n = 111 
e Wide confidence interval (CI) is a result of only one control having this symptom 
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Comparisons by Severity of Autism Spectrum Disorder 
Comparisons of AU versus ASD, as originally defined in the CHARGE 
study, suggest that GI symptoms and related issues are similar be-
tween the two groups, with the exception of diarrhea (Table 2). Chil-
dren with AU have higher reports of diarrhea compared to children 
with ASD. 
Examination of GI Symptoms and ABC Scores 
We examined the association between GI symptoms and maladap-
tive behavior scores for the five subscales of the ABC. In children with 
ASD, four out of five behavior subscales (irritability, social withdrawal, 
stereotypy and hyperactivity) on the ABC were significantly higher in 
children with frequent occurrences of abdominal pain, gaseousness, 
diarrhea and constipation as compared to children with no frequent 
GI symptoms (Table 5). In addition, two or three of the behavior sub-
scales (irritability, social withdrawal, and stereotypy) on the ABC were 
significantly higher in children with other frequent GI symptoms (pain 
on stooling, sensitivity to food, and difficulty swallowing). For children 
with DD, maladaptive behavior scores for the ABC yielded a pattern 
of associations only for diarrhea: scores were higher for irritability (GI 
positive 16.7 SE 4.6, GI negative 8.6 SE 0.9, p = 0.06), social withdrawal 
(GI positive 8.6 SE 2.6, GI negative 4.0 SE 0.5, p = 0.09) and hyperac-
tivity subscales (GI positive 22.1 SE 4.8, GI negative 11.0 SE 1.0, p = 
0.02) in children whose parent reported frequent diarrhea versus in-
frequent diarrhea (Table 2S). 
Open–Ended questions 
Descriptive analyses of parental responses to related open ended 
GI questions indicated the most frequently reported food sensitivity 
or allergy for all diagnostic groups was dairy/casein (14.6 % ASD, 6.6 
% DD and 5.3 % TD). For children with ASD, other commonly reported 
food allergies or sensitivities included the grains category (including 
gluten, 7.8 %) and nuts/soy (7 %). The most commonly cited reason 
for food restrictions in children with ASD was child selectivity (8.6 %) 
followed by adverse GI symptoms (8.2 %); and for children with DD 































































s   
   
   
   
   
   
   
   
   






   
   
   
   
   
   









    
   
   
   
   
   
   






    
   
   
   
   
   
   
   







   
   
   
   


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a   
na
a   
na


















































































































C h a i d e z  e t  a l .  i n  J  A u t i s m  D e v  D i s o r d  4 4  ( 2 0 1 4 )       13
and TD it was adverse GI symptoms (DD 10.2 %, TD 4 %). The most 
commonly reported GI diagnosis across all groups was gastroesoph-
ageal reflux disorder (GERD), although in children with ASD (n = 18), 
half of these were reported to have resolved. Only 2 cases were re-
ported in the disease category for celiac disease/colitis, 1 in ASD (0.4 
%) and 1 in DD (1.5 %), whereas an additional 6 cases in ASD (1.2 %) 
reported malabsorption, leaky gut or abnormal stool and five children 
with DD (nearly 4 %) had GI anatomical abnormalities. Five cases of 
dysbiosis (yeast in stool) were also reported in children with ASD (1 %). 
We also examined the types of combinations for children with two 
or more reported frequent GI symptoms in the last 3 months. In a 
majority of cases, diarrhea and constipation occur in mutually exclu-
sive groups. For example, in children with ASD, only 9 reported both 
diarrhea and constipation, while 29 reported diarrhea in combina-
tion with other symptoms, and 44 reported constipation with other 
symptoms. In children with DD, only 3 children had both diarrhea and 
constipation, while another 3 reported diarrhea in combination with 
other GI symptoms, and 8 reported constipation in combination with 
other GI symptoms. 
Discussion 
Our findings from the largest population-based case–control study 
of GI problems in children with ASD and DD confirmed using stan-
dardized tests indicate that these symptoms, particularly constipation 
and diarrhea, affect children with ASD and DD far more often than 
children with TD. Compared to children with TD, children with ASD 
and DD were at least three times more likely to experience a higher 
frequency of most GI symptoms. After adjustment for medications, 
the odds ratios were changed very little (with the exception of diffi-
culty swallowing in the ASD analysis, reported for only one TD con-
trol). Exceedingly strong differences in reported frequency of diarrhea, 
constipation, gaseousness/bloating and sensitivity to foods were ro-
bust across models, with prevalences five to nine-fold higher in ASD. 
What remains to be understood are the mechanisms or contributing 
factors that can help explain these differences. 
Comparison of our findings to other studies yielded some nota-
ble similarities. For example, Valicenti-McDermott et al. in a New York 
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sample of slightly older children (mean age 7.6 years, SD ± 3.6) re-
ported food selectivity at similar prevalences (ASD 60 %, TD 22 %, 
and DD 36 %) as food dislikes in our California sample (ASD 63.5 %, 
TD 34 %, and DD 34.6 %). Abnormal stool patterns (defined as recur-
rent passage of ≥3 large unformed stools daily for >4 weeks) were 
reported only slightly more often in cases (ASD 18 %, TD 4 %, DD 2 
%); as compared with reports of diarrhea in our sample (ASD 13 %, 
TD 2 %, DD 6 %). 
In contrast to our findings, Ibrahim et al. found that the overall in-
cidence of GI symptoms did not differ between children with autism 
and gender- and age-matched children with typical development. In 
the Ibrahim study, information from medical charts covered birth to 
21 years of age: constipation; diarrhea; abdominal bloating, discom-
fort or irritability; gastroesophageal reflux or vomiting; and feeding 
issues or food selectivity (Ibrahim et al. 2009). However, it was not 
indicated whether these findings included illnesses such as the flu, 
which could account for null findings, especially since their study in-
vestigated cumulative incidence of GI problems over a long time pe-
riod. In the CHARGE study, we collected information on GI problems 
occurring in the last 3 months. 
Interestingly, food selectivity for children with ASD is a common 
thread in several studies (Valicenti-McDermott et al. 2006; Ibrahim 
et al. 2009). Ibrahim et al. concluded that constipation and food se-
lectivity were attributed to behavioral characteristics of children with 
ASD such as ritualistic tendencies, need for routine, and insistence on 
sameness, rather than being indicative of GI pathology. Our results 
provide some support for these contentions in that children with ASD 
had not only the highest reports of food dislikes (a proxy for food se-
lectivity), but also the highest odds of reporting GI symptoms not ex-
plained by other factors such as the child’s age, medication or mater-
nal education. It is plausible that a child with notable food dislikes or 
selectivity for a variety of reasons such as taste, texture, or temper-
ature, might consume a relatively self-restricting diet that could re-
duce the variety of foods and nutrients needed to maintain healthy 
gut function. Only one study to date has examined dietary habits as 
a possible link between gastrointestinal dysfunction and autism, and 
findings suggested there was no association (Gorrindo et al. 2012). 
To our knowledge, only the Valicenti-McDermott study and ours 
offer a comprehensive comparison of GI problems in ASD children 
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versus those having other developmental disorders. One recent study 
assessed the prevalence of various medical conditions, including one 
GI symptom, using a nationally representative sample of children ages 
3–17 years and found the prevalence of frequent diarrhea/ colitis in 
the past 12 months was seven times more likely in children with au-
tism [6.8 %, aOR 7.1, 95 % CI (3.9–12.8)] and three times more likely 
in children with a developmental disability [3 %, aOR 3.5, 95 % CI 
(2.7–4.5)] than children with typical development (0.9 %; Schieve et 
al. 2012). 
In comparing our findings with others, we note that despite the 
similarities in the DD groups between Valicenti- McDermott and our 
study, the two groups are not quite the same. Our CHARGE Study DD 
group is designated as having a developmental delay, regardless of 
the cause, i.e., it includes those with known chromosomal, genetic or 
mitochondrial disorders whereas Valicenti- McDermott designates the 
DD group as children with developmental disabilities and they exclude 
from both the ASD and DD groups, those with ‘‘known genetic’’ syn-
dromes or disorders. In either case, comparisons to children with DD 
provide information on the specificity of findings in ASD: overall, GI 
symptoms were more prevalent in both ASD and DD children when 
comparing with TD children, signifying a lack of specificity in regard 
to this phenotypic presentation. When we compared subsets within 
the ASD group, ASD children with DD versus ASD children without 
DD did not, in the main, differ in their GI symptoms. The one excep-
tion was for vomiting, but given that no other symptoms differed and 
that it was a relatively infrequently reported GI symptom, the finding 
is likely due to chance. 
Our findings in children with ASD demonstrating a consistent rela-
tionship between GI symptoms and maladaptive behaviors have per-
haps special clinical translational significance, with possible implica-
tions for treatment approaches. Similar to the strong and significant 
relationship we found between GI symptoms and increased measures 
of irritability, social withdrawal, stereotypy, and hyperactivity, Nikolov 
et al. observed that children with PDDs and GI problems (all symp-
toms combined) showed greater symptom severity on measures of 
irritability and social withdrawal on the ABC, as well as anxiety, and 
to our knowledge is the only other study addressing GI problems 
and behavior of children with ASDs (Nikolov et al. 2009). It is plau-
sible that a chronic GI symptom, which can cause pain, discomfort 
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and anxiety, could contribute to increased irritability and social with-
drawal, particularly in someone with deficits in social and communi-
cative skills. Furthermore, for a child with ASD, increased stereotypy 
and hyperactivity may represent coping mechanisms for an uncom-
fortable and unpredictable GI condition. A recent report found that 
behavioral characteristics hypothesized to be expressions of GI prob-
lems are common in children with ASD, yet not specific to those with 
GI problems (Maenner et al. 2012). Therefore the authors suggested 
that the presence of these behaviors would not be useful on their own 
for screening or identifying children requiring GI evaluation. However, 
many ASD children, most especially those who are non-verbal, often 
do not present with symptoms typically recognized by many primary 
care physicians or specialists as being GI related, such as self-injuri-
ous behavior (SIB) and aggression that may be responses to pain and/
or discomfort. Until clinicians and therapists consider a thorough GI 
history as a possible explanation for adverse behaviors, GI disorders 
in this population will continue to be over-looked and insufficiently 
treated. Appropriate treatment of GI symptoms may help alleviate at 
least some problematic behaviors and improve the quality of life in 
children with ASD along with their families. A recent consensus report 
on the evaluation, diagnosis and treatment of GI disorders in children 
with ASD supports the use of medical investigation for problem be-
haviors (Statement 7) and provides examples and guidance for clini-
cians (Buie et al. 2010a). 
In children with DD, diarrhea was the only GI symptom associated 
with measures of maladaptive behaviors, specifically irritability, social 
withdrawal and hyperactivity. As in ASD, clinicians attending to chil-
dren with DD should inquire about GI conditions, particularly where 
behavioral problems or recent changes in behavior have been noted. 
Larger sample sizes and analyses focused on both idiopathic and spe-
cific etiologies of DD should be investigated to understand the role of 
GI problems in children with DD, and their relationship with a child’s 
behavior. 
Comparisons between children with AU and those with ASD yielded 
very similar GI profiles with the exception of diarrhea. The ten percent-
age point higher prevalence in those with the more severe diagnosis 
(AU) might indicate that greater severity induces more co-morbidity 
or alternatively, that the presence of chronic diarrhea increases symp-
tom severity. Wang and colleagues also reported on autism symptom 
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severity and odds of having GI problems showing that having ‘‘Full Au-
tism’’ (aOR 14.28, 95 % CI 6.22–32.77) or ‘‘Almost Autism’’ (aOR 5.16, 
95 % CI 2.02–13.21) were strongly associated with experiencing GI 
problems in multiplex families affected with autism compared to un-
affected siblings (Wang et al. 2011). Diarrhea was one of the two most 
reported GI problems in children with ASD. 
Dairy and/or casein were cited most often as food allergens among 
all groups of children. However, it is unclear to what degree these par-
ent-reports reflect true food allergies versus food sensitivities. At least 
one group of researchers has demonstrated that in children with ASD, 
it is nonallergic food hypersensitivity to cow’s milk protein (CMP), and 
not casein that plays a role in GI symptoms observed in some chil-
dren with ASD (Jyonouchi et al. 2005). Food allergies are often difficult 
to diagnose because most intestinal food allergies are cell mediated 
rather than by immunoglobulin E (IgE) (Buie et al. 2010b). Cell-medi-
ated immunity plays a role in non-allergic food hypersensitivity and 
reactions take place several hours and even 1–2 days after the intake 
of the culprit (Jyonouchi et al. 2005). Finally, it is possible that reported 
food allergens may be neither an allergy or sensitivity, but rather a 
parent’s or child’s perception or opinion of a particular food(s). 
For children with ASD, parents report child selectivity as the primary 
reason for diet restriction, followed closely by adverse GI symptoms. 
Although it makes sense for child refusal and adverse GI symptoms 
to be common reasons for diet restrictions, we would have expected 
more parents to report food allergy as a reason for imposing a diet 
restriction considering the number of food allergies or sensitivities 
reported. Diagnoses of celiac disease were rare, which is interest-
ing given the sizable number reporting a food allergy to grains and/
or gluten. A limitation of our study is that these findings are based 
solely on parent-report rather than medical chart review for diagnos-
tic testing. 
Among our study’s other limitations is the lack of standardized def-
initions for GI symptoms. This makes it difficult to make comparisons 
across studies. Our data was based on parent report, so there will be 
a level of inherent subjectivity, which on the one hand is a limitation, 
but for children in this age range, parents are likely best suited to fol-
low and report bowel habits and GI symptoms that may not be reli-
ably recorded in medical records. Furthermore, dietary intake infor-
mation for the children is also lacking. Diarrhea and constipation are 
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frequently cited in studies examining GI symptoms in children with 
autism, but to date, only one has examined the role of diet in GI prob-
lems (Gorrindo et al. 2012). To investigate whether diet plays a role in 
the prevalence of GI problems, future studies should attempt to mea-
sure diet quality and quantity of key macronutrients with special at-
tention to fiber, water, and fats, in addition to micronutrients such as 
iron, zinc, vitamin A, vitamin B12, folate and iodine. One small study 
suggests that children with ASDs may have inadequate intakes of fi-
ber, calcium, iron, vitamin E and vitamin D (Herndon et al. 2009). 
Among the strengths of this analysis are: the CHARGE Study pop-
ulation-based sample, which provided a broader ethnic diversity of 
cases and controls than previous studies; the large sample size of 
nearly 1,000 children; and adjustment for confounding from both so-
ciodemographic factors and medications. In addition to demonstrat-
ing a much higher incidence of parent-reported frequent diarrhea, 
gaseousness/bloating, constipation, and food sensitivities in 2–5 years 
old children with ASD versus their typically developing counterparts, 
this study identified a strong correlation between deviant behaviors 
and the presence of GI symptoms in both children with ASD and DD. 
This underscores the need for clinical medical intervention and at-
tention to GI symptoms in these children. Future work examining GI 
problems in children with ASD and DD should standardize definitions 
for GI symptoms and more studies need to incorporate measures of 
dietary intake and nutritional status. 
The variety of GI symptoms evident within a significant portion of 
the ASD population may be reflective of the heterogeneity of the dis-
order in general. Further, the neurotransmitter systems that are ac-
tive in the brain can also be found to function in the gut, which has 
been referred to as ‘the second brain’ (de Theije et al. 2011). Thus, it 
is possible that research into GI symptoms might elucidate aspects of 
the underlying neurobiological mechanisms associated with the dis-
order. Investigating the dual role of neurotransmitters active in both 
the gut and the brain in future studies may advance our understand-
ing of underlying mechanisms important to both. 
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Table 1S. Comparison of ‘Current’ GI symptomsa (in the past 3 months) for cases (ASD, with 





with DD DD P valueb
n=377 n=114 n=136
GI symptomsc % % %
Abdominal pain 5.8% 4.7% 4% 0.82
Gaseousness/bloating sensation 9.4% 11.4% 2.4% 0.003
Diarrhea 8.9% 14.4% 6.2% 0.02
Constipation 13.6% 15.5% 15.9% 0.86
Pain on stooling 6.5% 5.6% 5.6% 0.94
Vomiting 5.4% 1.6% 6.2% 0.02
Sensitivity to foods 29.4% 31.6% 11.2% <0.0001
Difficulty swallowing 5.5% 3.3% 4.7% 0.55
Blood in stools 0.9% 0.3% 0.8% 0.35
Blood in vomit 0.9% 0% 0% 0.19
aThose reporting symptoms occur 'frequently' or 'always' on Likert scale 
bP values calculated using chi-square test; Fisher's exact test used where applicable
cNumber of missing data for entire sample varies from 1-39  
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